Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xylem Inc. Director's Dealing 2026

Mar 3, 2026

30109_dirs_2026-03-03_d2265453-026a-415b-baf1-1a4e2d9db7bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2026-03-01

Reporting Person: Cho Albert (EVP, Strategy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-03-01 Common Stock A 1311 $128.98 Acquired 15418 Direct
2026-03-01 Common Stock A 1082 $128.98 Acquired 16500 Direct
2026-03-01 Common Stock A 735 $128.98 Acquired 17235 Direct
2026-03-01 Common Stock A 587 $128.98 Acquired 17822 Direct
2026-03-02 Common Stock A 1042 Acquired 18864 Direct
2026-03-02 Common Stock F 1610 $128.98 Disposed 17254 Direct
2026-03-02 Common Stock F 295 $128.98 Disposed 16959 Direct
2026-03-02 Common Stock F 371 $128.98 Disposed 16588 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-03-02 Non-Qualified Stock Options (Right to Buy) $128.98 A 3713 Acquired 2036-03-02 Common Stock (3713) Direct

Footnotes

F1: Reflects the acquisition of 1,311 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

F2: Includes additional shares due to dividend reinvestment.

F3: Reflects the acquisition of 1,082 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.

F4: Reflects the acquisition of 735 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.

F5: Reflects the acquisition of 587 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.

F6: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

F7: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).

F8: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

F9: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (207) and March 1, 2024 (164) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

F10: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.